Adenosine deaminase inhibitor

This page covers all Adenosine deaminase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Adenosine deaminase (ADA).

Targets

Adenosine deaminase (ADA)

Phase 3 pipeline (1)

• Adezunap (AP707) · Apurano Pharmaceuticals GmbH · Immunology
  Adezunap is a small-molecule inhibitor of adenosine deaminase that increases intracellular adenosine and deoxyadenosine levels to promote immune cell apoptosis and reduce inflammation.

Patent intelligence

• adenosine deaminase inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates